Joan Murphy

3.6k total citations
43 papers, 2.1k citations indexed

About

Joan Murphy is a scholar working on Epidemiology, Reproductive Medicine and Oncology. According to data from OpenAlex, Joan Murphy has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 14 papers in Reproductive Medicine and 12 papers in Oncology. Recurrent topics in Joan Murphy's work include Cervical Cancer and HPV Research (16 papers), Ovarian cancer diagnosis and treatment (12 papers) and BRCA gene mutations in cancer (11 papers). Joan Murphy is often cited by papers focused on Cervical Cancer and HPV Research (16 papers), Ovarian cancer diagnosis and treatment (12 papers) and BRCA gene mutations in cancer (11 papers). Joan Murphy collaborates with scholars based in Canada, United States and Ireland. Joan Murphy's co-authors include Barry P. Rosen, Steven A. Narod, Terence J. Colgan, David E.C. Cole, Amy Finch, Patricia Shaw, Stéphane Laframboise, Rochelle Demsky, Denny DePetrillo and Allan Covens and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Joan Murphy

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Murphy Canada 21 986 675 532 479 441 43 2.1k
Ranjit Manchanda United Kingdom 25 847 0.9× 1.2k 1.8× 477 0.9× 323 0.7× 109 0.2× 142 2.2k
Deborah E. Powell United States 26 907 0.9× 224 0.3× 310 0.6× 651 1.4× 280 0.6× 81 2.0k
Eloise Chapman‐Davis United States 22 482 0.5× 325 0.5× 549 1.0× 383 0.8× 138 0.3× 95 1.6k
B.J. Rimel United States 23 1.1k 1.1× 424 0.6× 1.4k 2.7× 369 0.8× 201 0.5× 113 2.6k
Ashley Stuckey United States 25 248 0.3× 384 0.6× 648 1.2× 221 0.5× 120 0.3× 85 1.9k
Michael E. Carney United States 18 928 0.9× 158 0.2× 392 0.7× 549 1.1× 114 0.3× 41 1.6k
Christopher P. DeSimone United States 22 1.0k 1.0× 139 0.2× 314 0.6× 587 1.2× 253 0.6× 53 1.7k
Cor D. de Kroon Netherlands 34 1.3k 1.3× 137 0.2× 768 1.4× 1.7k 3.5× 393 0.9× 118 3.4k
Robert V. Higgins United States 26 1.0k 1.0× 120 0.2× 428 0.8× 911 1.9× 543 1.2× 64 2.0k
Steven C. Plaxe United States 24 745 0.8× 109 0.2× 623 1.2× 706 1.5× 243 0.6× 102 1.8k

Countries citing papers authored by Joan Murphy

Since Specialization
Citations

This map shows the geographic impact of Joan Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Murphy more than expected).

Fields of papers citing papers by Joan Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Murphy. The network helps show where Joan Murphy may publish in the future.

Co-authorship network of co-authors of Joan Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Murphy. A scholar is included among the top collaborators of Joan Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Murphy. Joan Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Erik E. L., Bronwen R. McCurdy, Rachel Kupets, et al.. (2025). Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study. Medical Decision Making. 45(5). 545–556. 1 indexed citations
2.
Jembere, Nathaniel, et al.. (2022). Are Women with Antecedent Low-Grade Cytology and <CIN2 Findings in Colposcopy Being Overmanaged?. Journal of Obstetrics and Gynaecology Canada. 44(10). 1054–1060.
3.
Jackson, Rebecca, Li Wang, Nathaniel Jembere, Joan Murphy, & Rachel Kupets. (2018). Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?. Journal of Lower Genital Tract Disease. 23(1). 1–6. 5 indexed citations
4.
Tota, Joseph E., J. Bentley, Jennifer Blake, et al.. (2017). Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Preventive Medicine. 98. 5–14. 82 indexed citations
5.
Tota, Joseph E., J. Bentley, Jennifer Blake, et al.. (2017). Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Preventive Medicine. 98. 15–20. 30 indexed citations
6.
Sander, Beate, et al.. (2016). The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting – Can we do better?. Vaccine. 34(16). 1936–1944. 5 indexed citations
7.
Rouzbahman, Marjan, Suzanne Kamel‐Reid, Ayman Al Habeeb, et al.. (2015). Malignant Melanoma of Vulva and Vagina. Journal of Lower Genital Tract Disease. 19(4). 350–353. 36 indexed citations
8.
Fox, Edward, Jeanna McCuaig, Rochelle Demsky, et al.. (2015). The sooner the better: Genetic testing following ovarian cancer diagnosis. Gynecologic Oncology. 137(3). 423–429. 17 indexed citations
9.
Murphy, Joan, et al.. (2015). The Organization of Colposcopy Services in Ontario: Recommended Framework. Current Oncology. 22(4). 287–296. 4 indexed citations
10.
Eiriksson, Lua, Clare J. Reade, Felix Leung, et al.. (2015). Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer. International Journal of Gynecological Cancer. 25(5). 809–814. 15 indexed citations
11.
Rosen, Barry P., Stéphane Laframboise, Sarah E. Ferguson, et al.. (2014). The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer. Gynecologic Oncology. 134(3). 462–467. 94 indexed citations
13.
Murphy, Joan, Erin B. Kennedy, Sheila Dunn, et al.. (2012). Cervical Screening: A Guideline for Clinical Practice in Ontario. Journal of Obstetrics and Gynaecology Canada. 34(5). 453–458. 51 indexed citations
14.
Bentley, J., Monique Bertrand, Hélène Gagné, et al.. (2012). RETIRED: Colposcopic Management of Abnormal Cervical Cytology and Histology. Journal of Obstetrics and Gynaecology Canada. 34(12). 1188–1202. 66 indexed citations
15.
Finch, Amy, Kelly Metcalfe, Laurie Elit, et al.. (2011). The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecologic Oncology. 121(1). 163–168. 154 indexed citations
16.
Chu, William, Anthony Fyles, Edward M. Sellers, et al.. (2007). Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use. Carcinogenesis. 28(10). 2139–2142. 29 indexed citations
17.
McLachlin, C. Meg, Verna Mai, Joan Murphy, et al.. (2007). Ontario Cervical Cancer Screening Clinical Practice Guidelines. Journal of Obstetrics and Gynaecology Canada. 29(4). 344–353. 16 indexed citations
18.
Finch, Amy, Patricia Shaw, Barry P. Rosen, et al.. (2005). Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecologic Oncology. 100(1). 58–64. 263 indexed citations
19.
Laframboise, S., et al.. (2002). Use of CA-125 and ultrasound in high-risk women. International Journal of Gynecological Cancer. 12(1). 86–91. 30 indexed citations
20.
Colgan, Terence J., Scott Boerner, Joan Murphy, et al.. (2002). Peritoneal Lavage Cytology: An Assessment of Its Value during Prophylactic Oophorectomy. Gynecologic Oncology. 85(3). 397–403. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026